Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury

Peptides

Volumn 30, Issue 4, 2009, Pages 715-720

  Ruohonen, Suvi T ^a,b   Abe, Ken ^b   Kero, Mia ^a   Toukola, Laura ^a   Ruohonen, Saku ^a   Röyttä, Matias ^a   Koulu, Markku ^a   Pesonen, Ullamari ^a   Zukowska, Zofia ^b   Savontaus, Eriika ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c TYKSLAB   (Finland)

Author keywords

Neointimal hyperplasia; Neuropeptide Y; Transgenic mouse; Vascular injury

Indexed keywords

NEUROPEPTIDE Y;

ADRENERGIC SYSTEM; ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMORAL ARTERY; GENE OVEREXPRESSION; HYPERPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING;

ANIMALS; BETA-GALACTOSIDASE; FEMORAL ARTERY; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; SYMPATHETIC NERVOUS SYSTEM; TRANSGENES; TUNICA INTIMA;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 62949202885     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.12.009     Document Type: Article

References (48)

1. Black P.H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 67 4 (2006) 879-891
2. Bodary P.F., Shen Y., Ohman M., Bahrou K.L., Vargas F.B., Cudney S.S., et al. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 27 1 (2007) 70-76
3. Bodary P.F., Westrick R.J., Wickenheiser K.J., Shen Y., and Eitzman D.T. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 287 13 (2002) 1706-1709
4. Chadjichristos C.E., Matter C.M., Roth I., Sutter E., Pelli G., Luscher T.F., et al. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113 24 (2006) 2835-2843
5. Edvinsson L. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries. Acta Physiol Scand 125 1 (1985) 33-41
6. Ekblad E., Edvinsson L., Wahlestedt C., Uddman R., Hakanson R., and Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 8 3 (1984) 225-235
7. Erami C., Zhang H., Ho J.G., French D.M., and Faber J.E. Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am J Physiol Heart Circ Physiol 283 4 (2002) H1577-H1587
8. Erlinge D., Brunkwall J., and Edvinsson L. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regul Pept 50 3 (1994) 259-265
9. Erlinge D., Yoo H., Edvinsson L., Reis D.J., and Wahlestedt C. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol 265 4 Pt 2 (1993) H1089-1097
10. Han S., Yang C.L., Chen X., Naes L., Cox B.F., and Westfall T. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction. Am J Physiol 274 1 Pt 2 (1998) H290-294
11. Jaakkola U., Pesonen U., Vainio-Jylha E., Koulu M., Pollonen M., and Kallio J. The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy. Exp Clin Endocrinol Diabetes 114 4 (2006) 147-152
12. Kallio J., Pesonen U., Kaipio K., Karvonen M.K., Jaakkola U., Heinonen O.J., et al. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. Faseb J 15 7 (2001) 1242-1244
13. Karvonen M.K., Pesonen U., Koulu M., Niskanen L., Laakso M., Rissanen A., et al. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 4 12 (1998) 1434-1437
14. Karvonen M.K., Valkonen V.P., Lakka T.A., Salonen R., Koulu M., Pesonen U., et al. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis 159 1 (2001) 145-151
15. Kobayashi K., Morita S., Mizuguchi T., Sawada H., Yamada K., Nagatsu I., et al. Functional and high-level expression of human dopamine beta-hydroxylase in transgenic mice. J Biol Chem 269 47 (1994) 29725-29731
16. Kobayashi K., Sasaoka T., Morita S., Nagatsu I., Iguchi A., Kurosawa Y., et al. Genetic alteration of catecholamine specificity in transgenic mice. Proc Natl Acad Sci USA 89 5 (1992) 1631-1635
17. Koulu M., Movafagh S., Tuohimaa J., Jaakkola U., Kallio J., Pesonen U., et al. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann Med 36 3 (2004) 232-240
18. Kuo L.E., Abe K., and Zukowska Z. Stress, NPY and vascular remodeling: implications for stress-related diseases. Peptides 28 2 (2007) 435-440
19. Li L., Jonsson-Rylander A.C., Abe K., and Zukowska Z. Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors. Arterioscler Thromb Vasc Biol 25 10 (2005) 2075-2080
20. Li L., Lee E.W., Ji H., and Zukowska Z. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler Thromb Vasc Biol 23 7 (2003) 1204-1210
21. Majewski H., Hedler L., Schurr C., and Starke K. Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II. J Cardiovasc Pharmacol 6 5 (1984) 888-896
22. Malmstrom R.E. Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo. Regul Pept 95 1-3 (2000) 59-63
23. Matter C.M., Ma L., von Lukowicz T., Meier P., Lohmann C., Zhang D., et al. Increased balloon-induced inflammation, proliferation, and neointima formation in apolipoprotein E (ApoE) knockout mice. Stroke 37 10 (2006) 2625-2632
24. Mercer E.H., Hoyle G.W., Kapur R.P., Brinster R.L., and Palmiter R.D. The dopamine beta-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron 7 5 (1991) 703-716
25. Mills P.J., Dimsdale J.E., Ziegler M.G., Hauger R.L., Nelesen R.A., and Brown M.R. Sympathetic alterations after sodium restriction and short-term captopril administration. J Am Coll Cardiol 21 1 (1993) 177-181
26. Mountford P.S., and Smith A.G. Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet 11 5 (1995) 179-184
27. Nilsson T., and Edvinsson L. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors. Can J Physiol Pharmacol 78 3 (2000) 256-259
28. Niskanen L., Karvonen M.K., Valve R., Koulu M., Pesonen U., Mercuri M., et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab 85 6 (2000) 2266-2269
29. Niskanen L., and Voutilainen-Kaunisto R. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes. Exp Clin Endocrinol Diabetes 108 3 (2000) 235-236
30. Paran E., Neumann L., and Cristal N. Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment. Eur J Clin Pharmacol 43 1 (1992) 11-15
31. Pesonen U., Koch W., Schomig A., and Kastrati A. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting. J Endovasc Ther 10 3 (2003) 566-572
32. Pons J., Kitlinska J., Jacques D., Perreault C., Nader M., Everhart L., et al. Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth. Can J Physiol Pharmacol 86 7 (2008) 438-448
33. Ruohonen S.T., Pesonen U., Moritz N., Kaipio K., Roytta M., Koulu M., et al. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance. Diabetes 57 6 (2008) 1517-1525
34. Ruohonen ST, Savontaus E, Rinne P, Rosmaninho-Salgado J, Cavadas C, Ruskoaho H, Koulu M, Pesonen U. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons. Neuroendocrinology; 2008 doi:10.1159/000188602, in press.
35. Sata M., Maejima Y., Adachi F., Fukino K., Saiura A., Sugiura S., et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 32 11 (2000) 2097-2104
36. Shigeri Y., and Fujimoto M. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells. Neurosci Lett 149 1 (1993) 19-22
37. Stassen F.R., Maas R.G., Schiffers P.M., Janssen G.M., and De Mey J.G. A positive and reversible relationship between adrenergic nerves and alpha-1A adrenoceptors in rat arteries. J Pharmacol Exp Ther 284 1 (1998) 399-405
38. Stephenson K., Tunstead J., Tsai A., Gordon R., Henderson S., and Dansky H.M. Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol 23 11 (2003) 2027-2033
39. Wallerstedt S.M., Skrtic S., Eriksson A.L., Ohlsson C., and Hedner T. Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population. J Hypertens 22 7 (2004) 1277-1281
40. Wang X., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C. Mouse models of neointimal hyperplasia: techniques and applications. Med Sci Monit 12 9 (2006) RA177-RA185
41. Wang X., and Paigen B. Comparative genetics of atherosclerosis and restenosis: exploration with mouse models. Arterioscler Thromb Vasc Biol 22 6 (2002) 884-886
42. Zeng C., Wang X., Liu G., and Yang C. Effects of ACE inhibitor and beta-adrenergic blocker on plasma NPY and NPY receptors in aortic vascular smooth muscle cells from SHR and WKY rats. Neuropeptides 36 5 (2002) 353-361
43. Zhang H., Facemire C.S., Banes A.J., and Faber J.E. Different alpha-adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro. Am J Physiol Heart Circ Physiol 282 6 (2002) H2364-H2370
44. Zhu B., Kuhel D.G., Witte D.P., and Hui D.Y. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am J Pathol 157 6 (2000) 1839-1848
45. Zukowska-Grojec Z., and Neuropeptide Y. A novel sympathetic stress hormone and more. Ann N Y Acad Sci 771 (1995) 219-233
46. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Fisher T.A., and Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept 75-76 (1998) 231-238
47. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83 2 (1998) 187-195
48. Zukowska-Grojec Z., Pruszczyk P., Colton C., Yao J., Shen G.H., Myers A.K., et al. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14 2 (1993) 263-268